OTC Pharmaceuticals - Burundi

  • Burundi
  • The OTC Pharmaceuticals market in Burundi is projected to generate a revenue of US$10.56m in 2024.
  • With an expected annual growth rate of 10.48% (CAGR 2024-2029), this market is poised for expansion.
  • Among the various markets, Vitamins & Minerals leads the pack with a market volume of US$2.67m in 2024.
  • In a global context, the in the United States dominates with the highest revenue of US$41,240.00m in the same year.
  • In terms of per capita revenues, each individual in Burundi is estimated to contribute US$0.78 in 2024.
  • Additionally, online sales are predicted to account for 1.04% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Burundi's OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies due to cultural beliefs and limited access to modern healthcare.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Burundi has been experiencing steady growth in recent years.

Customer preferences:
In Burundi, customers have shown a strong preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of these products. OTC medications are readily available in pharmacies and drugstores across the country, allowing customers to easily purchase them without a prescription. Additionally, customers often prefer OTC medications for minor ailments and common health issues, as they are perceived to be more affordable and convenient compared to prescription medications.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Burundi is the increasing demand for preventive healthcare products. Customers are becoming more proactive in taking care of their health and are seeking OTC products that can help prevent illnesses and promote overall well-being. This trend is driven by a growing awareness of the importance of preventive healthcare and a desire to avoid costly medical treatments.Another trend in the market is the rising popularity of herbal and natural remedies. Customers in Burundi are increasingly turning to traditional herbal medicines and natural supplements for their healthcare needs. This trend is driven by a cultural preference for traditional remedies and a belief in their effectiveness. Additionally, customers are becoming more conscious of the potential side effects of synthetic medications and are seeking safer alternatives.

Local special circumstances:
Burundi is a low-income country with limited access to healthcare services. This has led to a reliance on self-medication and the use of OTC pharmaceutical products. Due to the high cost of prescription medications and the limited availability of healthcare professionals, customers often turn to OTC medications as a first-line treatment option. This has created a strong demand for OTC pharmaceutical products in the country.

Underlying macroeconomic factors:
The growth of the OTC Pharmaceuticals market in Burundi can be attributed to several underlying macroeconomic factors. Firstly, the country has been experiencing steady economic growth, which has led to an increase in disposable income and improved living standards. As a result, customers have more purchasing power and are able to afford OTC medications.Secondly, Burundi has a young and growing population, which is driving the demand for healthcare products. The country's population is increasingly becoming aware of the importance of healthcare and is seeking affordable and accessible solutions. This has created a favorable market environment for OTC pharmaceutical products.In conclusion, the OTC Pharmaceuticals market in Burundi is developing due to customer preferences for convenience and accessibility, as well as the increasing demand for preventive healthcare products and natural remedies. The local special circumstances, such as limited access to healthcare services, also contribute to the growth of the market. Additionally, underlying macroeconomic factors, such as economic growth and a young population, further drive the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)